Stress Reduction Using Video Googles on Patients Undergoing Vascular Surgery
Launched by UNIVERSITY HOSPITAL AUGSBURG · Nov 22, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether using video goggles can help reduce stress and discomfort for patients undergoing a specific type of surgery called carotid endarterectomy. This surgery is performed while the patient is awake, which can sometimes lead to anxiety and distress due to the long duration of the procedure and the sterile environment. The researchers want to see if watching videos can distract patients and make their experience more comfortable.
To participate in this trial, individuals must be between the ages of 65 and 74 and scheduled for carotid endarterectomy under local anesthesia. However, those who cannot communicate due to a stroke, language barrier, or who have conditions like dementia that affect their understanding are not eligible. If participants join the study, they can expect to wear video goggles during their surgery, and the researchers will assess how this affects their stress levels during the procedure. This trial is currently recruiting participants, and its findings could lead to better experiences for patients undergoing similar surgeries in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Planed carotid endarterectomy in local anesthesia
- Exclusion Criteria:
- • patients which are not able to communicate because of stroke or language barrier,
- • Dementia or neurological damage which impairs answering questionnaires or the understanding of the situation during surgery
- • medication with steroids
About University Hospital Augsburg
University Hospital Augsburg is a leading academic medical center located in Augsburg, Germany, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital integrates cutting-edge medical practices with rigorous scientific inquiry, fostering collaborations between multidisciplinary teams of researchers, clinicians, and patients. With a commitment to enhancing patient outcomes and contributing to the global medical community, University Hospital Augsburg emphasizes ethical standards, patient safety, and the development of novel therapeutic approaches in various fields of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Augsburg, Bavaria, Germany
Patients applied
Trial Officials
Alexander Hyhlik-Dürr, Prof. Dr.
Study Director
Vascular Surgery Faculty of Medicine University of Augsburg, Stenglinstr. 2 86156 Augsburg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported